News
PYPD
5.21
+3.58%
0.18
Weekly Report: what happened at PYPD last week (0907-0911)?
Weekly Report · 6d ago
Weekly Report: what happened at PYPD last week (0831-0904)?
Weekly Report · 09/07 09:49
Weekly Report: what happened at PYPD last week (0824-0828)?
Weekly Report · 08/31 09:54
Weekly Report: what happened at PYPD last week (0817-0821)?
Weekly Report · 08/24 09:54
Weekly Report: what happened at PYPD last week (0810-0814)?
Weekly Report · 08/17 09:55
Analysts Are Bullish on These Healthcare Stocks: PolyPid (PYPD), Equillium (EQ)
TipRanks · 08/14 02:30
PolyPid Earnings Call: Priority Review, Big Azurity Deal
TipRanks · 08/13 00:12
PolyPid Posts Wider H1 2026 Loss as Assets and Equity Decline
TipRanks · 08/12 21:17
PolyPid Advances D-PLEX100; FDA Grants Priority Review
NASDAQ · 08/12 18:45
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD)
TipRanks · 08/12 16:50
PolyPid Wins FDA Priority Review for D-PLEX₁₀₀ and Locks In $30 Million Azurity Milestones
TipRanks · 08/12 11:57
PolyPid Q2 EPS $(0.35) Beats $(0.38) Estimate
Benzinga · 08/12 11:30
Weekly Report: what happened at PYPD last week (0803-0807)?
Weekly Report · 08/10 09:51
Weekly Report: what happened at PYPD last week (0727-0731)?
Weekly Report · 08/03 09:51
PolyPid rises as lead product granted FDA priority review
Seeking Alpha · 07/29 18:20
PolyPid NDA acceptance ‘meets or exceeds’ expectations, says Roth Capital
TipRanks · 07/29 15:30
PolyPid's NDA For D-PLEX100 Receives FDA Priority Review, Stock Up
NASDAQ · 07/29 14:55
PolyPid announces FDA acceptance of, priority review for D-PLEX100
TipRanks · 07/29 13:01
PolyPid Wins FDA Priority Review for D-PLEX100 NDA, Accelerating Path to Market
TipRanks · 07/29 12:57
PolyPid Announces FDA Acceptance Of Its New Drug Application With A Priority Review For D-PLEX100 For The Prevention Of Surgical Site Infections In Patients Undergoing Abdominal Colorectal Surgery; PDUFA Action Date Is November 28
Benzinga · 07/29 12:34
More
Webull provides a variety of real-time PYPD stock news. You can receive the latest news about Polypid Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About PYPD
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.